Impact of SARS-CoV-2 RNAemia and other risk factors on long-COVID: A prospective observational multicentre cohort study - 28/01/23
Doi : 10.1016/j.jinf.2022.11.009
Alexander Rombauts a, 1, Carmen Infante b, c, d, 1, Mikel del Álamo Martínez de Lagos e, Jorge Alba f, Adoración Valiente g, Carla Donado-Mazarrón a, Marta Carretero-Ledesma b, c, Regino Rodríguez-Álvarez e, Sonia Omatos f, Zaira R. Palacios-Baena g, Gabriela Abelenda-Alonso a, María del Mar Silva-Sánchez b, c, Ane Josune Goikoetxea-Agirre e, José A. Oteo f, Jesús Rodríguez-Baño d, g, h, Elisa Cordero b, c, d, h, Carlota Gudiol a, d, i, Javier Sánchez-Céspedes b, c, d, ⁎ 
, Jordi Carratalà a, d, i
, Jordi Carratalà a, d, i a Department of Infectious Diseases, Hospital Universitari de Bellvitge – Bellvitge Biomedical Research Institute (IDIBELL), L´Hospitalet de Llobregat, Barcelona, Spain
b Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Virgen del Rocío University Hospital, Seville, Spain
c Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain
d Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
e Department of Infectious Diseases, Hospital Universitario Cruces, Bizkaia, Spain
f Department of Infectious Diseases, San Pedro-CIBIR University Hospital, Logroño, La Rioja, Spain
g Unit of Infectious Diseases and Microbiology, Virgen Macarena University Hospital, Seville, Spain
h Department of Medicine, School of Medicine, University of Seville, Seville, Spain
i Universitat de Barcelona, Barcelona, Spain
⁎Corresponding author at: Viral Diseases and Infections in Immunodeficiencies Research Group, Institute of Biomedicine of Seville (IBiS). Virgen del Roc.ío University Hospital/CSIC/University of Seville, Seville, Spain, Tel: +34 955 923 104.Viral Diseases and Infections in Immunodeficiencies Research GroupInstitute of Biomedicine of Seville (IBiS)Virgen del Roc.ío University Hospital/CSIC/University of SevilleSevilleSpain
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Highlights |
• | Long-COVID is a major problem for physicians and health care policy makers. |
• | SARS-CoV-2 RNAemia is associated with worse quality of life. |
• | SARS-CoV-2 RNAemia is associated with more long-COVID symptoms. |
• | SARS-CoV-2 RNAemia was not associated with any specific long-COVID symptom. |
Keywords : COVID-19, SARS-CoV-2 RNAemia, Viral load, Long-COVID, Risk factors
© 2022
Publié par Elsevier Masson SAS.
Vol 86 - N° 2
P. 154-225 - février 2023 Retour au numéro
Article précédent
- Continuing evolution and transmission of avian influenza A(H3N8) viruses is a potential threat to public health
- Jiangtao Zhou, Yiqun Chen, Zheng Shao, Shiping Ding, Wenbao Qi, Jiahao Zhang, Lihong Huang
- Safety and immunogenicity of a bivalent SARS-CoV-2 recombinant protein vaccine, SCTV01C in unvaccinated adults: A randomized, double-blinded, placebo-controlled, phase I clinical trial
- Guiqiang Wang, Kexin Zhao, Jun Han, Zhongyu Hu, Tianzuo Zhang, Yanchao Wang, Rui Shi, Yanhua Li, Qinqin Song, Haijun Du, Peng He, Shuping Xu, Xinjie Yang, Yongpan Fu, Yimin Cui, Liangzhi Xie
Bienvenue sur EM-consulte, la référence des professionnels de santé.